Katharina Schreeb

Dr. Schreeb, a renowned clinical leader with 25+ years in global pharmaceuticals and biotech. Former CMO & VP at Sangamo Therapeutics, she shaped global biotech leadership at BioNTech overseeing clinical development and regulatory strategy. With roles at big pharma, including Boehringer Ingelheim, Eli Lilly, and Pharmacia, she's a regulatory expert, funding leader, and magna cum laude graduate, authoring 25+ scientific papers. Expertise across CGT, Oncology, Rare Disease and Autoimmune, including AI platforms.